Prof. Anna Boguszewska-Czubara is a research professor at the Department of Medical Chemistry, Medical University of Lublin, Poland. She holds an MSc in Chemistry from Maria Curie-Skłodowska University and a PhD in Medical Sciences (medical biology) awarded in 2009. Her scientific activity is focused on molecular and cellular biology in oncology, with particular emphasis on experimental pharmacology and toxicology using advanced in vitro and in vivo models.
She is the author of ci 160 peer-reviewed publications (total IF ≈ 380, H-index 26). Her research of particular importance includes studies on the application of metal–organic frameworks (MOFs) as detoxifying materials, evaluated for biocompatibility and biological safety, as well as investigations into the anticancer potential of nanomaterials, including targeted nanoparticles assessed in cellular and animal cancer models. These works combine molecular, biochemical and cellular endpoints to explore cytotoxicity, oxidative stress, apoptosis and therapeutic efficacy.
She has led and participated in multiple competitive research projects funded by the National Science Centre (OPUS) and EU programs. Prof. Boguszewska-Czubara serves as Head of the Quality Assurance Unit in the GLP-certified Laboratory at the Centre for Experimental Medicine in Lublin, contributing to the development of high-quality preclinical research.
Prof. Anna Boguszewska-Czubara is a research professor at the Department of Medical Chemistry, Medical University of Lublin, Poland. She holds an MSc in Chemistry from Maria Curie-Skłodowska University and a PhD in Medical Sciences (medical biology) awarded in 2009. Her scientific activity is focused on molecular and cellular biology in oncology, with particular emphasis on experimental pharmacology and toxicology using advanced in vitro and in vivo models.
She is the author of ci 160 peer-reviewed publications (total IF ≈ 380, H-index 26). Her research of particular importance includes studies on the application of metal–organic frameworks (MOFs) as detoxifying materials, evaluated for biocompatibility and biological safety, as well as investigations into the anticancer potential of nanomaterials, including targeted nanoparticles assessed in cellular and animal cancer models. These works combine molecular, biochemical and cellular endpoints to explore cytotoxicity, oxidative stress, apoptosis and therapeutic efficacy.
She has led and participated in multiple competitive research projects funded by the National Science Centre (OPUS) and EU programs. Prof. Boguszewska-Czubara serves as Head of the Quality Assurance Unit in the GLP-certified Laboratory at the Centre for Experimental Medicine in Lublin, contributing to the development of high-quality preclinical research.